|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
About Dr. Brewitt
She is the leader in evidence-based medicine, internationally recognized for her scientific and clinical studies on homeopathic growth hormone and growth factors. Dr. Brewitt's valued peer-reviewed published work on cell signaling is translated into five different languages. With nine (9) International and US patents to her name, Dr. Brewitt's interest in integrating science, theology and medicine motivated her to attain a PhD from the University of Washington, and do post-doctoral research on growth factors' effects on cell health and repair at the National Institutes of Health (NIH). She also received a Master of Divinity from the lliff School of Theology. The Cell Signal Enhancer (CSE®) innovation of Dr. Brewitt's is like no other in the market. These innovative discoveries arose from her work as a scientist, visionary, minister, and socially responsible activist. |
|
Dr. Barbara Brewitt is founder, CEO and Chief Scientific Officer of Biomed
Comm® Inc., a Seattle based company she founded in 1996. Dr.
Brewitt bridges the effectiveness of cell signaling with the safety and accessibility
of natural medicines.